"10.1371_journal.pone.0115726","plos one","2014-12-22T00:00:00Z","Thomas A Zangle; Michael A Teitell; Jason Reed","Department of Bioengineering, University of California Los Angeles (UCLA), Los Angeles, California, United States of America; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States of America; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America; California NanoSystems Institute, UCLA, Los Angeles, California, United States of America; Broad Stem Cell Research Center, UCLA, Los Angeles, California, United States of America; Molecular Biology Institute, UCLA, Los Angeles, California, United States of America; Department of Physics, Virginia Commonwealth University (VCU), Richmond, Virginia, United States of America; VCU Massey Cancer Center, Richmond, Virginia, United States of America","Conceived and designed the experiments: TAZ JR MAT. Performed the experiments: TAZ. Analyzed the data: TAZ JR MAT. Contributed reagents/materials/analysis tools: TAZ JR. Wrote the paper: TAZ JR MAT.","A patent application on the LCI technology has been filed by UCLA OIPA with MAT and JR listed as co-inventors. U.S. patent application names and number #1: Michael A. Teitell, Jason C. Reed, and James K. Gimzewski; Optical Cytometry, U.S. Serial Number 12/436,702 U.S. provisional patent application names and number #2: Michael A. Teitell and Jason C. Reed; Rapid, Massively Parallel Single-Cell Drug Response Measurements Via Live Cell Interferometry, U.S. Serial Number 61/514,353. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS One policies on sharing data and materials.","2014","12","Thomas A Zangle","TAZ",3,TRUE,3,1,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
